학술논문

The CCR5 Gene Edited CD34+CD90+ Hematopoietic Stem Cell Population Serves as an Optimal Graft Source for HIV Gene Therapy.
Document Type
Article
Source
Frontiers in Immunology; 3/14/2022, Vol. 13, p1-15, 15p
Subject
HEMATOPOIETIC stem cells
GENOME editing
GENE therapy
CHEMOKINE receptors
CELL populations
Language
ISSN
16643224
Abstract
Copyright of Frontiers in Immunology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)